Protein Biochip Market Evolving From Promise to Products
San Francisco. The protein biochip industry is shedding hype and demonstrating real value. The grandiose visions of technologies to study the entire human proteome are giving way to pragmatic divide-and-conquer approaches. This transition is driving the projected growth in the market from $122 million in 2002 to more than $500 million in 2008, according to a new report, Protein Biochips: Parallelized Screening for High-Output Biology, from BioPerspectives in San Francisco, California, Bachmann consulting in Nesoddtangen, Norway, and the NMI Natural and Medical Sciences Institute at the University of Tuebingen in Germany.
The report, written by an international team of experts, has unparalleled analysis and coverage of the protein biochip market, including both planar and bead arrays. The report features a detailed discussion of the key drivers that are likely to cause major shifts in the emerging market, ranging from the content problem to the looming bottleneck in target validation to the current bottleneck in lead optimization to the enthusiasm over protein biomarkers. The comprehensive report features detailed evaluations of the technologies and business strategies of 60 companies, plus summaries of 9 companies currently using bead-based assays for diagnostics.
In addition, the report features a detailed, hierarchical market model. At the highest level, the market is divided into three application areas: (1) drug target and biomarker identification and validation, (2) drug development, and (3) clinical trials and diagnostics. At the next level, the market is divided by biochip dimension: 2-dimensional planar arrays and 3-dimensional bead arrays. The next level is the type of biochip: capture and interaction. At the lowest level: hardware and biochips.
Furthermore, to enable readers to take full advantage of the expertise of the authors, the report comes with one free hour of consulting. Steven Bodovitz and Jutta Bachmann will be available for conference calls to discuss market drivers, company evaluations, and financial projections.
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Last viewed contents
Brazilian Regulatory Body Approves Monsanto's Insect-Protected Bollgard Cotton
DARA BioSciences, Inc. and Point Therapeutics, Inc. Announce Consummation of Merger
Diehl Umwelttechnik Ges.mbH & Co KG - Netphen, Germany
CERTUSS Dampfautomaten GmbH & Co. KG - Krefeld, Germany
Xention Participates in €12 Million Atrial Fibrillation Research Consortium - Consortium awarded five-year European Union grant under Seventh Framework programme
r.z.w. cimdata AG - Weimar, Germany
DHL launches industry-changing temperature controlled Life Sciences air freight service - DHL Thermonet for temperature controlled air freight services for the Life Sciences and Healthcare sector
A 'bionic nose' that knows
